What Heartflow, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 17 | 40 |
| Total trades | 27 | 106 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 47,024 | 1,059,927 |
| Disposed | 335,782 | 9,430,060 |
| Net activity | −288,758 | −8,370,133 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Farquhar John C.m. | Chief Executive Officer | Nov 10 | Disclosed 10b5-1 sale · S | −38,900 | $55.74 | −$2.17M | 251,983 |
| Farquhar John C.m. | Chief Executive Officer | Nov 10 | Exercise / conversion · M | +15,620 | $2.22 | +$34.7K | 290,883 |
| Verghese Vikram | Chief Financial Officer | Nov 09 | Open-market sale · S | −3,587 | $53.15 | −$191K | 149,587 |
| Farquhar John C.m. | Chief Executive Officer | Nov 06 | Withheld — tax / exercise cost · F | −7,751 | $52.40 | −$406K | 275,263 |
| Verghese Vikram | Chief Financial Officer | Nov 06 | Withheld — tax / exercise cost · F | −2,009 | $52.40 | −$105K | 153,174 |
| Rogers Campbell | Chief Medical Officer | Nov 06 | Withheld — tax / exercise cost · F | −2,270 | $52.40 | −$119K | 71,183 |
| Jones Marie L. | Chief Accounting Officer | Nov 06 | Withheld — tax / exercise cost · F | −568 | $52.40 | −$29.8K | 32,403 |
| Rogers Campbell | Chief Medical Officer | Oct 22 | Open-market sale · S | −23,933 | $55.01 | −$1.32M | 73,453 |
| Rogers Campbell | Chief Medical Officer | Oct 22 | Exercise / conversion · M | +5,101 | $2.22 | +$11.3K | 97,386 |
| Rogers Campbell | Chief Medical Officer | Oct 22 | Exercise / conversion · M | +12,329 | $8.33 | +$103K | 92,285 |
| Farquhar John C.m. | Chief Executive Officer | Oct 12 | Open-market sale · S | −38,900 | $49.57 | −$1.93M | 283,014 |
| Verghese Vikram | Chief Financial Officer | Sep 18 | Open-market sale · S | −16,766 | $50.75 | −$851K | 155,183 |
| Rogers Campbell | Chief Medical Officer | Sep 18 | Open-market sale · S | −19,682 | $50.15 | −$987K | 79,956 |
| Rogers Campbell | Chief Medical Officer | Sep 18 | Exercise / conversion · M | +850 | $2.22 | +$1.89K | 99,638 |
| Rogers Campbell | Chief Medical Officer | Sep 18 | Exercise / conversion · M | +12,329 | $8.33 | +$103K | 98,788 |
| Verghese Vikram | Chief Financial Officer | Sep 17 | Open-market sale · S | −7,579 | $50.11 | −$380K | 171,949 |
| Verghese Vikram | Chief Financial Officer | Sep 15 | Open-market sale · S | −668 | $50.01 | −$33.4K | 179,528 |
| Verghese Vikram | Chief Financial Officer | Sep 14 | Open-market sale · S | −4,593 | $50.24 | −$231K | 180,196 |
| Farquhar John C.m. | Chief Executive Officer | Sep 11 | Open-market sale · S | −3,890 | $50.00 | −$195K | 321,914 |
| Verghese Vikram | Chief Financial Officer | Sep 11 | Open-market sale · S | −29,714 | $50.06 | −$1.49M | 184,789 |
Loading...